It is official folks, Takeda Pharmaceutical Co. has announced this week, that it will pay more than $2.4 billion to settle the pending Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker agrees to settle more than 9,000 Actos bladder cancer lawsuits in federal and state courts in the U.S.…
Takeda Pharmaceutical Co. has announced today that it will pay more than $2.4 billion to settle the pending Actos lawsuits over bladder cancer claims. Asia’s largest drugmaker agreed to settle more than 8,000 Actos bladder cancer lawsuits in federal and state courts in the U.S. Any settlement deal would average…
After 4 years of intense Actos litigation, surrounding the link between the use of Actos and the development of bladder cancer, Takeda Pharmaceuticals is signaling the raising of the white flag, by entering into a series of settlement discussions. Serious effort are underway to try and resolve all of the…